Related Experiment Video

Updated: Jun 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

p53 gene therapy using RNA interference

I Berindan-Neagoe1, O Balacescu, C Burz

  • 1Cancer Institute I.Chiricuta, Cluj Napoca, Romania. ioanaberi@iocn.ro

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|September 29, 2009
PubMed

Insights

The p53 tumor suppressor gene is frequently mutated in human cancers. RNA interference targeting p53 transcripts offers a novel therapeutic strategy for cancer, potentially overcoming delivery challenges.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The p53 gene is crucial for cell cycle control and apoptosis, and its mutation is implicated in over 50% of human cancers.
  • Various delivery systems for p53 gene therapy exist, but face challenges with immune response and efficacy.
  • RNA silencing technology, specifically RNA interference (RNAi), has emerged as a powerful tool for gene expression regulation.

Purpose of the Study:

  • To explore the potential of RNA interference targeting p53 transcripts as a cancer therapeutic strategy.
  • To investigate the use of nano-level carriers for enhanced delivery of RNAi targeting p53.

Main Methods:

  • Utilizing double-stranded RNA molecules, such as small interfering RNA (siRNA), for RNA interference against p53 transcripts.
  • Investigating the integration of RNAi technology with nano-level carriers for systemic delivery to tumor cells.

Main Results:

  • RNA silencing provides a method to inhibit post-transcriptional gene expression of p53.
  • The combination of RNAi and nano-carriers shows promise for developing new therapeutic models for cancer treatment.

Conclusions:

  • RNA interference targeting p53 transcripts, despite delivery challenges into mammalian cells, holds significant therapeutic potential for cancer.
  • Further development of delivery systems is crucial for realizing the full potential of p53-targeted RNAi in cancer therapy.

More Related Videos

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...